The effect of magnesium sulfate on maternal serum electrolytes and parathyroid hormone in pre-eclampsia

被引:2
|
作者
Farahani, Masoumeh [1 ]
Sharifinejad, Niusha [2 ]
Hashemnejad, Maryam [1 ]
Mashak, Banafsheh [3 ]
Mahboubipour, Hamid [4 ]
Farahani, Mahnaz [5 ]
Rastad, Hadith [2 ]
Nirouei, Matineh [5 ]
机构
[1] Alborz Univ Med Sci, Dept Obstet & Gynecol, Karaj, Iran
[2] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran
[3] Alborz Univ Med Sci, Sch Med, Dept Anesthesiol, Karaj, Iran
[4] Alborz Univ Med Sci, Gastroenterol, Karaj, Iran
[5] Alborz Univ Med Sci, Karaj, Iran
关键词
calcium; magnesium sulfate; parathyroid hormone; phosphorus; pre-eclampsia; serum electrolytes; HYPOCALCEMIA; THERAPY; CALCIUM; HYPERKALEMIA; HYPERMAGNESEMIA; EXCRETION; INFUSION;
D O I
10.1002/ijgo.14296
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To evaluate possible interactions of magnesium sulfate-the drug of choice in the management of pre-eclampsia/eclampsia-in response to a few case reports that revealed maternal electrolyte disturbances, especially symptomatic changes, following magnesium sulfate administration in pre-eclampsia. Methods Prospectively, women with pre-eclampsia were given 4 g of intravenous magnesium sulfate followed by a 2 g/h infusion up to 24 h after delivery. Sequential blood samples were drawn from each patient and used to measure the serum levels of sodium, potassium, calcium, phosphorus, magnesium, and parathyroid hormone. Results A total of 30 pregnant women with pre-eclampsia were evaluated. They were aged between 20 and 41 years with median gestational age of 37.6 (interquartile range 35.4-38.9) weeks. Only five patients reached the therapeutic window of magnesium in at least one of our measuring intervals during magnesium sulfate infusion. Plasma magnesium concentrations increased significantly during magnesium sulfate administration and dropped during the next 12 and 24 h after infusion discontinuation (P < 0.05). Fifteen of 30 (50%) patients developed asymptomatic hypocalcemia, mainly at hour 24 of infusion. Negative moderate correlations were detected between the calcium and magnesium concentrations at 12 and 24 hours of infusion (rho = -0.390, P = 0.044 and rho = 0.315, P = 0.096, respectively). None of the patients with hypocalcemia reached the therapeutic level of magnesium or experienced parallel hyperphosphatemia. Eleven of 30 (36.6%) patients developed hyperphosphatemia mainly at 2 and 12 h of magnesium sulfate infusion. Conclusions Our study implies that magnesium sulfate could cause hypermagnesemia-induced hypocalcemia in women with pre-eclampsia, independent from parathyroid hormone. The negative correlations between calcium and magnesium concentrations could be indicative of dose-dependent associations between serum magnesium level and degree of hypocalcemia in our study.
引用
收藏
页码:938 / 943
页数:6
相关论文
共 50 条
  • [31] Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia
    Cayci, Tuncer
    Akgul, E. Ozgur
    Kurt, Yasemin Gulcan
    Aydin, Ibrahim
    Alacam, Hasan
    Ozkan, Esin
    Yaman, Halil
    Cakir, Erdinc
    Deren, Ozgur
    Dogan, Pakize
    Bilgi, Cumhur
    Erbil, M. Kemal
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (08) : 1127 - 1131
  • [32] Association between the maternal serum levels of 19 eicosanoids and pre-eclampsia
    Long, Anxiong
    Ma, Shungao
    Li, Qian
    Lin, Na
    Zhan, Xia
    Lu, Shuaijun
    Zhu, Yuli
    Jiang, Liansheng
    Tan, Longyi
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 133 (03) : 291 - 296
  • [33] Hyaluronan and CD44 in maternal serum from pre-eclampsia
    Matejevic, D
    Bussen, S
    Steck, T
    Müller, T
    Dietl, J
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 1999, 203 (06): : 246 - 249
  • [34] The relationship of serum vitamin D with pre-eclampsia in the Iranian women
    Abedi, Parvin
    Mohaghegh, Zainab
    Afshary, Poorandokht
    Latifi, Mahmood
    MATERNAL AND CHILD NUTRITION, 2014, 10 (02) : 206 - 212
  • [35] Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia
    Berhan, Yifru
    Berhan, Asres
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2015, 41 (06) : 831 - 842
  • [36] Best evidence in anesthetic practice Prevention: Magnesium sulfate reduces the risk of eclampsia in women with pre-eclampsia
    Joanne Douglas
    Alison Macarthur
    Canadian Journal of Anesthesia, 2003, 50 : 1035 - 1038
  • [37] Best evidence in anesthetic practice - Prevention: Magnesium sulfate reduces the risk of eclampsia in women with pre-eclampsia
    Belfort, MA
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2003, 50 (10): : 1035 - 1036
  • [38] Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia
    Duley, Lelia
    Matar, Hosam E.
    Almerie, Muhammad Qutayba
    Hall, David R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (08):
  • [39] Effect of Magnesium Sulfate Concentration on Serum Ionized Magnesium In Vitro
    Salamon, Mia
    Mimouni, Francis B.
    Dollberg, Shaul
    Mandel, Dror
    AMERICAN JOURNAL OF PERINATOLOGY, 2010, 27 (07) : 525 - 528
  • [40] Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait
    Omu, A. E.
    Al-Harmi, J.
    Vedi, H. L.
    Mlechkova, L.
    Sayed, A. F.
    Al-Ragum, N. S.
    MEDICAL PRINCIPLES AND PRACTICE, 2008, 17 (03) : 227 - 232